The preparation method according to claim 1 or 2, wherein the coupling in step 2 is performed by condensing by DIC+A or B+A+C method until the resin is detected to be transparent with ninhydrin, wherein A is chosen from HOBt or HOAt, B is chosen from HBTU, HATU, TBTU, PyAOP, or PyBOP, C is chosen from DIPEA or TMP
doi: 10.1016/j.diabet.2019.101117 33 IkushimaIJensenLFlintANishidaTZachoJ
Studies extending to two years showed participants maintained approximately a 35 lb weight reduction, with weight-loss trajectories continuing for 65 weeks before stabilizing for up to four years
The brief report is the first study of its kind, the researchers say, to establish a link between the use of such drugs, called GLP-1 agonists, for weight loss and the risk of such gastrointestinal conditions
Injection site reactions, unusual fatigue , dizziness , and gastrointestinal symptoms beyond what the drug typically causes could indicate contamination
Wang, X